Metagenomi has filed with the U.S. Securities and Exchange Commission to raise $100,000,000.00 in an Initial Public Offering
According to filings with the U.S. Securities and Exchange Commission, Metagenomi is raising $100,000,000.00 in new funding. About Metagenomi: We harness the power of our proprietary metagenomics platform to create curative genetic medicines for patients….